MedTrace Logo

Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therapy During the Trial

NCT03277378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2021-01-05

Study results available
· View outcomes & findings →

Summary

Prospective, multi-center, randomized, single blind study

Conditions

  • Chronic, Intractable Pain of the Trunk and/or Lower Limbs

Interventions

DEVICE

lead placement followed by BurstDR stimulation

lead placement followed by BurstDR stimulation

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Robyn Capobianco, PhD · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-22
Primary Completion
2018-08-23
Completion
2018-10-12
FDA Device
Yes

Countries

  • United States
  • Australia
  • Austria
  • Germany
  • Italy
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03277378 on ClinicalTrials.gov